Stabilized Yellow Fever Vaccine

Vaccine type

Yellow Fever

Commercial Name

Manufacturer

Institut Pasteur de Dakar

URL

Responsible NRA

Ministère de la Santé publique

Country

Senegal

Prequalification Status

Current

Effective Date

20/03/2001

Pharmaceutical Form

Lyophilised active component to be reconstituted with excipient diluent before use

Presentation

Ampoule

Number of Doses

5

Diluent

0.9% Sodium Chloride

Route of Administration

Intramuscular or Subcutaneous

Shelf Life

36 months

Storage Temperature

2-8°C

Vaccine Vial Monitor

Type 14

Secondary Packaging

10

Multidose Vial Policy

Not Applicable.

Vaccine Preservative

none

Cold Chain Volume

2.7999999999999998 cm3/dose (in secondary packaging)